Clinical Trials Browser

Phase 3 × Nasopharyngeal Neoplasms × pembrolizumab × Clear all

NCT02611960 2023-07-13

Keynote-122

Phase 3 Completed

233 enrolled 21 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Nasopharyngeal Neoplasms